Damian McNamara is a journalist for Medscape Medical News and MDedge. He worked full-time for MDedge as the Miami Bureau covering a dozen medical specialties during 2001-2012, then as a freelancer for Medscape and MDedge, before being hired on staff by Medscape in 2018. Now the two companies are one. He uses what he learned in school – Damian has a BS in chemistry and an MS in science, health and environmental reporting/journalism. He works out of a home office in Miami, with a 100-pound chocolate lab known to snore under his desk during work hours.
News
Natalizumab bests fingolimod for relapsing-remitting MS
- Author:
- Damian McNamara
More patients taking natalizumab versus fingolimod reached NEDA at one year.
News
Initial high-efficacy MS therapy tied to less disability later
- Author:
- Damian McNamara
Starting treatment for relapsing-remitting multiple sclerosis (MS) with high-efficacy therapy (HET) is...
News

Predictors of ICH after thrombectomy identified
- Author:
- Damian McNamara
The sum of three variables may predict which patients undergoing thrombectomy up to 24 hours after a stroke are at higher risk of developing...
News
Trials and tribulations: Neurology research during COVID-19
- Author:
- Damian McNamara
Many researchers have redesigned their studies, at least in part to optimize the safety of their participants and research staff.
News
Two rare neurologic conditions linked to COVID-19
- Author:
- Damian McNamara
Two variants of Guillain-Barré syndrome—Miller Fisher syndrome and polyneuritis cranialis—have been linked with COVID-19 infection.
News
COVID-19 linked to large vessel stroke in young adults
- Author:
- Damian McNamara
The virus appears to cause disease through a process of blood clotting, according to an expert.
News
COVID-19: Are acute stroke patients avoiding emergency care?
- Author:
- Damian McNamara
Stroke specialists in New Orleans, Chicago, Seattle, and elsewhere are seeing a precipitous drop in the number of acute strokes at their...
News
Neurologic symptoms and COVID-19: What’s known, what isn’t
- Author:
- Damian McNamara
COVID-19 symptoms may include encephalopathy, ataxia, and other neurologic signs.
News
More evidence backs LDL below 70 to reduce recurrent stroke
- Author:
- Damian McNamara
LOS ANGELES – Targeting LDL below 70 mg/dL for more than 5 years avoided more than one in four subsequent major cardiovascular events among adults...
News
BASILAR: Endovascular treatment improves outcomes in BAO stroke
- Author:
- Damian McNamara
LOS ANGELES – Patients with a posterior basilar artery occlusion who received both endovascular therapy and thrombolysis were almost five times...
News

ARCADIA: Predicting risk of atrial cardiopathy poststroke
- Author:
- Damian McNamara
LOS ANGELES – First analysis of risk factors for atrial cardiopathy in patients with an embolic stroke of undetermined source may help to identify...
News
Shingles vaccine linked to lower stroke risk
- Author:
- Damian McNamara
Data from a large Medicare database showed a 20% decrease in stroke risk among adults who received the shingles vaccine.
News
Stroke risk tied to diabetic retinopathy may not be modifiable
- Author:
- Damian McNamara
LOS ANGELES – Findings from a subanalysis of the ACCORD Eye Study showed that glucose, lipid, and hypertension interventions did not mitigate the...
News

Treating LDL to below 70 reduces recurrent stroke
- Author:
- Richard Kirkner
- Damian McNamara
PHILADELPHIA – Results of TST, a rare cholesterol study in patients with a history of ischemic stroke, explore the benefits of treating to a lower...
News
PASI responses with biologics similar among white, nonwhite individuals, study finds
- Author:
- Damian McNamara
MIAMI– Investigators used data from psoriasis studies to determine whether treatment responses differed in skin of color patients.